Phio’s Cancer Drug Push Raises Costs as Cash Reserves Fall
KING OF PRUSSIA, PA — Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported a widening third-quarter loss and a nearly 50% decline in cash reserves as the King of Prussia biotechnology company …
Phio’s Cancer Drug Push Raises Costs as Cash Reserves Fall Read More